These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases. Mendelsohn AR; Larrick JW Rejuvenation Res; 2011 Aug; 14(4):437-41. PubMed ID: 21851176 [TBL] [Abstract][Full Text] [Related]
24. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential. Demidenko ZN; Blagosklonny MV Aging (Albany NY); 2009 Dec; 1(12):1008-16. PubMed ID: 20157583 [TBL] [Abstract][Full Text] [Related]
25. In search of nutritional anti-aging targets: TOR inhibitors, SASP modulators, and BCL-2 family suppressors. Sharma R; Padwad Y Nutrition; 2019 Sep; 65():33-38. PubMed ID: 31029919 [TBL] [Abstract][Full Text] [Related]
26. Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer. Anisimov VN Aging (Albany NY); 2013 May; 5(5):337-8. PubMed ID: 23715473 [No Abstract] [Full Text] [Related]
27. Inhibition of mTOR by Rapamycin Aggravates Corneal Epithelial Stem Cell Deficiency by Upregulating Inflammatory Response. Park JW; Ko JH; Kim BH; Ryu JS; Kim HJ; Kim MK; Oh JY Stem Cells; 2019 Sep; 37(9):1212-1222. PubMed ID: 31102490 [TBL] [Abstract][Full Text] [Related]
29. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway. Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648 [TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells. Bu X; Le C; Jia F; Guo X; Zhang L; Zhang B; Wu M; Wei L Cancer Biol Ther; 2008 Mar; 7(3):392-6. PubMed ID: 18075305 [TBL] [Abstract][Full Text] [Related]
32. Rapamycin retards epigenetic ageing of keratinocytes independently of its effects on replicative senescence, proliferation and differentiation. Horvath S; Lu AT; Cohen H; Raj K Aging (Albany NY); 2019 May; 11(10):3238-3249. PubMed ID: 31136303 [TBL] [Abstract][Full Text] [Related]
33. TOR-inhibitors as gero-suppressors. Nikiforov M Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970 [No Abstract] [Full Text] [Related]
34. Fluorofenidone inhibits UV-A induced senescence in human dermal fibroblasts via the mammalian target of rapamycin-dependent SIRT1 pathway. Lei D; Huang Y; Xie H; Yi Y; Long J; Lin S; Huang C; Jian D; Li J J Dermatol; 2018 Jul; 45(7):791-798. PubMed ID: 29726032 [TBL] [Abstract][Full Text] [Related]
35. Rapamycin, anti-aging, and avoiding the fate of Tithonus. Richardson A J Clin Invest; 2013 Aug; 123(8):3204-6. PubMed ID: 24063054 [TBL] [Abstract][Full Text] [Related]
36. Relief with rapamycin: mTOR inhibition protects against radiation-induced mucositis. Finkel T Cell Stem Cell; 2012 Sep; 11(3):287-8. PubMed ID: 22958927 [TBL] [Abstract][Full Text] [Related]